Literature DB >> 6874280

Detection of cytoplasmic S-100 protein in primary and metastatic intraocular melanomas.

A J Cochran, G N Holland, D R Wen, H R Herschman, W R Lee, R Y Foos, B R Straatsma.   

Abstract

The authors sought S-100 protein in sections cut from formalin- or glutaraldehyde-fixed, paraffin-embedded tumors from the eye and other sites by an immunoperoxidase technique, using rabbit antibovine S-100 protein antiserum, swine antirabbit serum, a peroxidase-antiperoxidase preparation, and amino-ethylcarbizole as developer. Tissue from 26 intraocular tumors was examined, the pathologic diagnosis being unknown to the investigators at that time that the tests were performed. Thirteen of 16 malignant melanomas of the choroid contained S-100 protein (81%), while only one of seven retinoblastomas contained S-100 protein (14%). One cutaneous malignant melanoma metastatic to the eye contained S-100 protein, while none of three metastatic nonmelanocytic, nonneural tumors contained the protein. These results are similar to our findings with nonocular tumors, in which 56 of 56 cutaneous melanomas contained S-100 protein (100%) and only 1 of 51 nonneural, nonmelanocytic tumors contained S-100 protein (2%). S-100 protein may be useful as a marker for ocular malignant melanoma.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6874280

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  12 in total

1.  Diagnostic immunopathology.

Authors:  P A Cancilla; A J Cochran; F Naeim; J W Said
Journal:  West J Med       Date:  1986-07

2.  Immunohistochemical evidence of neuronal and glial differentiation in retinoblastoma.

Authors:  K P Xu; S L Liu; C Ni
Journal:  Br J Ophthalmol       Date:  1995-08       Impact factor: 4.638

3.  S-100 protein stimulates cellular proliferation.

Authors:  J R Klein; D S Hoon; J Nangauyan; E Okun; A J Cochran
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

4.  Granular cell tumor of the lower lid: histological and immunohistochemical studies.

Authors:  T Ishibashi; T Yoshitomi; Y Ohnishi; Y Daimaru
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1984       Impact factor: 3.117

5.  Ultrastructural pathology of melanomalytic glaucoma.

Authors:  P G McMenamin; W R Lee
Journal:  Br J Ophthalmol       Date:  1986-12       Impact factor: 4.638

6.  Detection and quantification of S-100 protein in ocular tissues and fluids from patients with intraocular melanoma.

Authors:  A J Cochran; G N Holland; R E Saxton; B E Damato; W R Foulds; H R Herschman; R Y Foos; B R Straatsma; W R Lee
Journal:  Br J Ophthalmol       Date:  1988-11       Impact factor: 4.638

Review 7.  Proteomics of uveal melanoma: a minireview.

Authors:  Søren K O Abildgaard; Henrik Vorum
Journal:  J Oncol       Date:  2013-09-03       Impact factor: 4.375

8.  Immunohistochemical expression of melan-A and tyrosinase in uveal melanoma.

Authors:  Bruno F Fernandes; Alexandre N Odashiro; Vinicius S Saraiva; Patrick Logan; Emilia Antecka; Miguel N Burnier
Journal:  J Carcinog       Date:  2007-04-20

9.  Prognosis of conjunctival melanomas in relation to histopathological features.

Authors:  U Fuchs; T Kivelä; K Liesto; A Tarkkanen
Journal:  Br J Cancer       Date:  1989-02       Impact factor: 7.640

10.  Tissue distribution and differential expression of melanocortin 1 receptor, a malignant melanoma marker.

Authors:  F Salazar-Onfray; M López; A Lundqvist; A Aguirre; A Escobar; A Serrano; C Korenblit; M Petersson; V Chhajlani; O Larsson; R Kiessling
Journal:  Br J Cancer       Date:  2002-08-12       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.